In Vitro Activity of Iclaprim, a Novel Diaminopyrimidine, Tested against ß-Haemolytic Streptococci from the U.S. and Europe: Results from the International Study of Iclaprim Susceptibility (ISIS).
In Vitro Activity of Iclaprim, a Novel Diaminopyrimidine, Tested against ß-Haemolytic Streptococci from the U.S. and Europe: Results from the International Study of Iclaprim Susceptibility (ISIS)., Lead author: Sader HS, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL
